Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Mispro Biotech Services Announces Partnership with The Hamner Institutes for Health Sciences
Preclinical experts open vivarium facility in Research Triangle Park - February 28, 2013 - The Hamner Institutes for Health Sciences
Sengenics to Launch Global Biomarker Discovery and Clinical Trials Service Based on Oxford Gene Technology’s Patented Functional Protein Array
Sengenics today announced that it has signed an agreement with Oxford Gene Technology (OGT) to enable the launch of a global cancer biomarker discovery and clinical trial immuno-response monitoring service. The service will be based upon OGT’s proprietary full-length functional protein array... - February 25, 2013 - Sengenics
New Efficient Reagent for Stem Cell Transfection
DreamFect™ Stem transfection reagent from Oz Biosciences is specifically developed for transfection of Stem Cell. - February 23, 2013 - OZ Biosciences
GenScript Upgrade Free Bioinformatics Tools
GenScript provides a comprehensive range of online bioinformatics tools for Molecular Biology, Peptide, and Protein Researchers，as well as many other common bioinformatics tools. - February 23, 2013 - GenScript USA Inc.
World's First FDA Cleared ALK Automated Gene Scanner for Lung Cancer Therapy-Selection Available from ASI
Targeting the Right Treatment for the Right Patient in ALK Therapy Selection for Non-Small-Cell Lung Cancer - February 16, 2013 - Applied Spectral Imaging
Xeno Diagnostics, LLC Receives Award for Laboratory Excellence
Xeno Diagnostics, LLC Recognized for Quality Laboratory Services - February 15, 2013 - Xeno Diagnostics, LLC
iMPak Health Announces Agreement to License HealthSaaS Connected Outcomes Platform
iMPak Health, a subsidiary of Meridian Health, today announced a white labeling agreement with HealthSaaS for their Connected Outcomes Platform. This agreement will enhance iMPak’s device offerings by bringing patient data into the clinical workflow as an asset while reducing manual data entry and providing actionable information to healthcare providers. - February 13, 2013 - HealthSaaS, Inc
AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits
AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity – the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits. The former utilizes a FRET (fluorescent resonance energy transfer)-based peptide substrate and the latter, a... - February 09, 2013 - AnaSpec, EGT Group
GenScript Launches eBlot® Protein Transfer System
GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers. - February 07, 2013 - GenScript USA Inc.
Rosellini Scientific Chosen as a National Biomedical Vendor for Hospital Corporation of America and MedAssets
Rosellini Scientific, LLC, a biomedical engineering firm specializing in enhancing rehabilitation services for patients, has been approved as a national biomedical vendor for Hospital Corporation of America and MedAssets. - February 06, 2013 - Rosellini Scientific, LLC
Bioo Scientific Releases NEXTflex™ 16S V4 Amplicon-Seq Kit for Bacterial Metagenomics Studies
The NEXTflex™ 16S V4 Amplicon-Seq Kit has been developed to simplify bacterial metagenomics studies using Illumina® HiSeq and MiSeq platforms. This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available. Using specialized NEXTflex... - February 06, 2013 - Bioo Scientific
GenScript Launches New PolyExpress Package
With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. - February 03, 2013 - GenScript USA Inc.
New Independent Validation Study of ProtoCOL 3 System Shows System's Rapid Performance is as Accurate as Manual Colony Counting
Synbiosis, a world-leading manufacturer of automated microbiological systems, is delighted to announce its ProtoCOL 3 rapid automated colony counter has been shown in an independent study to perform with the same level of accuracy as manual colony counting for enumerating 10 different types of microbial colonies on a range of agar plates. - February 02, 2013 - Synbiosis
Stem Cell Expert Dr. R. Wade McKenna to Speak at International Stem Cell Society Conference
Biologic Therapies (www.biologictherapies.com), a medical device company specializing in the design and manufacturing of proprietary medical components focused on autologous stem cell therapy and regenerative medicine, has announced its Chief Medical Director, Dr. R. Wade McKenna, will share his... - January 29, 2013 - Biologic Therapies
MOgene Announces Partnership with Intuitive Genomics to Expand Bioinformatics Capabilities
MOgene LC, a full service genomics service provider based in Saint Louis, MO announces a partnership with Intuitive Genomics, Inc. to further expand its bioinformatics capabilities. This decision follows several years of successfully working with Intuitive Genomics to deliver some very promising... - January 28, 2013 - MOgene, LC
ProteinSignal - A New Brand of GenScript, Focused on Protein Research
ProteinSignal will serve as a pioneering developer and supplier of high performance protein research products covering the entire protein analysis workflow. Their offerings include cytokines and growth factors, protein purification resins, precast PAGE gels, protein standards, gel staining systems, anti-tag antibodies, western blot detection, ELISA kits and endotoxin detection and removal kits. - January 27, 2013 - GenScript USA Inc.
Samir Patel to Give Keynote at 5th Ocular Diseases Conference Mar 21-22, 2013
Samir Patel, President and CEO at Ophthotech to Give a Keynote Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
Peter Adamson of GSK to Speak at 5th Ocular Diseases Conference Mar 21-22, 2013
Peter Adamson, Vice President and Head of Research and Ophthalmology at GlaxoSmithKline to Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
Gary Novack of PharmaLogic to Speak at 5th Ocular Diseases Conference March 2013
Gary Novack, President at PharmaLogic Development to Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
Barbara Wirostko to Speak at 5th Ocular Diseases Conference Mar 21-22, 2013
Barbara Wirostko, Chief Scientific Officer and Co-Founder of Jade Therapeutics and Clinical Adjunct Associate Professor of Ophthalmology at University of Utah to Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA). - January 12, 2013 - GTCbio
AnaSpec Offers a Wide Selection of SYBR® qPCR MasterMixes and Core Kits
AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry. - January 12, 2013 - AnaSpec, EGT Group
Dr. Raymond Deshaies Speak at 3rd Ubiquitin Research and Drug Discovery Conference Feb 25-26, 2013 in Las Vegas, NV
3rd Ubiquitin Research and Drug Discovery Conference organized by GTCbio company. - January 10, 2013 - GTCbio
Dr. Aaron Ciechanover 2004 Nobel Prize Co-Winner Speak at Ubiquitin Research Conference (Organized by GTCbio company) Feb 25-26, 2013 in Las Vegas, NV
Dr. Aaron Ciechanover 2004 Nobel Prize Co-Winner and distinguished research professor in the Technion - Israel Institute of Technology in Haifa Will Give The Keynote Address “Intracellular Proteolysis and The Ubiquitin System: From The Backyard to The Center Stage of Biomedicne" at the 3rd Ubiquitin Research and Drug Discovery Conference organized by GTCbio company. - January 10, 2013 - GTCbio
ASI Launches Go-Path – Computerized Immunohistochemistry Cancer Analysis Aid
GenASIs Go-Path – Industry’s Most Advanced Computer Aided Membrane and Nuclear Immunohistochemistry Imaging and Analysis Platform - January 09, 2013 - Applied Spectral Imaging
ImmunoReagents Signs French Distributorship Agreement with Ozyme
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Ozyme as its new distributor in France. ImmunoReagents and Ozyme will partner to distribute top quality antibodies and... - January 04, 2013 - ImmunoReagents Inc.
ImmunoReagents Signs Swiss Distributorship Agreement with LabForce Ag
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of LabForce as its new distributor in Switzerland. ImmunoReagents and LabForce will partner to distribute top quality... - December 20, 2012 - ImmunoReagents Inc.
Applied Spectral Imaging Launches Version 7.2 of GenASIs – A New Era in Pathology and Cytogenetic Imaging
GenASIs 7.2 – The Market’s Most Comprehensive Computer Aided Cytogenetic and Pathology Imaging and Analysis Platform - December 20, 2012 - Applied Spectral Imaging
Charles W. Stiefel Appointed to M.D. Anderson Cancer Center Board of Visitors
Pharmaceutical Executive and Philanthropist Charles W. Stiefel has been appointed to the Board of Visitors of M.D. Anderson Cancer Center. - December 11, 2012 - Charles Stiefel Philanthropy
ALPCO Diagnostics and BioCat GmbH Sign Exclusive Distribution Agreement at MEDICA 2012
Beginning January 1, 2013, BioCat GmbH will be ALPCO's exclusive distributor in Germany. - December 10, 2012 - ALPCO
ALPCO Diagnostics and Euro Diagnostica Announce Distribution Agreement
ALPCO to distribute Euro Diagnostica products in North America. - December 07, 2012 - ALPCO
John F. Robyt, Ph.D. Recognized by Strathmore's Who's Who Worldwide Publication
John F. Robyt, Ph.D. of Ames, Iowa has been included in the Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of education. About John F. Robyt, PH.D. Dr. Robyt has over 52 years experience in the field of education. He is a... - December 07, 2012 - Strathmore Worldwide
Bruker Wins Over $7 Million in SP9900+ 3D Optical Microscope Orders
Instrument Breaks the Throughput Barrier for HDI Substrate Metrology - December 07, 2012 - Bruker Corporation
The Hamner Institutes for Health Sciences Announces Integrated Biology Initiative
Multi-Organization Partnership Will Promote Innovative Toxicity Testing Research - December 07, 2012 - The Hamner Institutes for Health Sciences
Bruker Introduces Proprietary IRIS TERS Probes
High-Contrast, Proven TERS Probe Tips for Complete Innova-IRIS TERS Solution - December 01, 2012 - Bruker Corporation
PeakForce Tapping Gains Rapid Adoption as Revolutionary AFM Mode
Over 100 Research Citations in 3 Years - December 01, 2012 - Bruker Corporation
Bruker Advances Universal Mechanical Tester (UMT) Design
New UMT Increases Flexibility and Seamlessly Integrates Optical Profiling and Mechanical Testing - December 01, 2012 - Bruker Corporation
Bruker Releases AFM Zoom Option for 3D Optical Microscopes
NanoLens™ Accessory Expands Power of ContourGT Systems - December 01, 2012 - Bruker Corporation
AutoWeb Technologies Announces the Launch of the New Sun Diagnostics Web Site for Patients, Clinicians, Laboratories, and Researchers in the in Vitro Diagnostics Field
Sun Diagnostics, located in New Gloucester, Maine, develops cutting-edge products for the ever-evolving IVD industry. They are very pleased to launch their new corporate web site. - November 30, 2012 - AutoWeb Technologies
2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing, which is going to be held on October 15-17, 2013 at Las Vegas, USA. - November 26, 2012 - OMICS Group Incorporation
Pipette.com Now Offers the Versatile CAPP Tempo Controller
Pipette.com has enhanced the pipetting experience by adding the new CAPP Tempo Controller to its product line of Liquid Handling products. The CAPP Tempo Controller was designed around CAPP manufacturing principles of making products built to last with limitless versatility and convenience that... - November 14, 2012 - Pipette.com
Nanion Introduces NPC-Certified Cell Lines
Nanion now introduces “Nanion Approved Cells” where commercially available cell lines from several providers have been evaluated and certified based on cell and platform performance for automated patch clamp. - November 10, 2012 - Nanion Technologies GmbH
Hepatitis B Foundation and Institute for Hepatitis and Virus Research Host Biotech Success-Themed Regional Biotech Conference
Philadelphia-area Entrepreneurs Share Biotech Success Stories During the Worst of Economic Times at Regional Industry Conference - November 08, 2012 - Hepatitis B Foundation
Rosellini Scientific, LLC Announces Recent Hire of Dr. Austin Duke as Vice President of Emerging Technologies
Rosellini Scientific, LLC is pleased to announce the recent hire of Dr. Austin Duke to join their team as Vice President of Emerging Technologies. - October 26, 2012 - Rosellini Scientific, LLC
International Conference and Exhibition on Otolaryngology
International Conference and Exhibition on Otolaryngology was organized by OMICS Group on October 15-17, 2012 at DoubleTree by Hilton Chicago-Northshore, USA. Otolaryngology-2012 was graced by leading scientists across the globe. - October 21, 2012 - OMICS Group Incorporation
International Conference on Biothreats and Biodefense
International Conference on Biothreats and Biodefense was organized by OMICS Group on October 15-17, 2012 at DoubleTree by Hilton, Chicago, USA. Biodefence-2012 was attended by researchers from academia, corporate and defense organizations in the various scientific disciplines like Formal Sciences, Applied Sciences, Natural Sciences and Social Sciences. - October 21, 2012 - OMICS Group Incorporation
Captiva Spine’s TowerLOX™ Minimally Invasive Pedicle Screw System Receives Clearance from FDA
Captiva Spine, Inc., a medical device organization dedicated to developing and distributing spinal technologies (in the U.S. and globally), today announced that it has received 510(k) clearance from the U.S. Food and Drug administration (FDA) to market the TowerLOX™ Minimally Invasive Lumbar Surgery System. - October 18, 2012 - Captiva Spine, Inc
Alpha Orthopaedics’ AT3™ System Receives CE Mark Certification, Further Prepares Alpha Orthopaedics to Enter World-Wide Markets
Alpha Orthopaedics’ innovative AT3™ System featuring RelēF Technology has received CE Mark. The FDA had previously cleared the AT3 System for commercial distribution in the U.S. RelēF Technology is used for the relief of pain associated with conditions such as tendinosis and fasciosis. This CE mark completes company’s preparation for global market launch, which included a successful completion of its pivotal trial and a side-by-side evaluation showing superiority over PRP. - October 17, 2012 - Alpha Orthopaedics, Inc.
VersaSuite Receives CCHIT Clinical Research Certification
VersaSuite 8.0 is the first ever product to receive CCHIT’s add-on Clinical Research Certification. - October 16, 2012 - VersaSuite
ImmunoReagents Signs Indian Distributorship Agreement with Labex Corporation
ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Labex Corporation as its new distributor in India. - October 10, 2012 - ImmunoReagents Inc.
Results of Type C Guidance Meeting with Food & Drug Administration (FDA) of ZYDIS® ODT Fluoxetine in the Treatment of Repetitive Behaviors in Autism
Autism Therapeutics LLC ("Autism Therapeutics") announced today that the Type C Guidance Meeting with FDA to discuss the ZYDIS® ODT Fluoxetine / Autism program has taken place. The FDA and Autism Therapeutics discussed the completion of the Phase III development of the program... - October 09, 2012 - Autism Therapeutics LLC